LAMIVUDINE WITH STAVUDINE

Lamivudine with Stavudine is a combination medication used in the management of HIV (human immunodeficiency virus) infections. It contains two active ingredients: Lamivudine and Stavudine. Lamivudine belongs to the class of nucleoside reverse transcriptase inhibitors (NRTIs), while Stavudine is also an NRTI. This combination works by inhibiting the activity of reverse transcriptase, an enzyme crucial for the replication of the virus.

Indications

This medication is indicated for the treatment of HIV infections in adults and pediatric patients. It is part of antiretroviral therapy (ART) regimens to suppress viral replication, improve immune function, and slow down the progression of the disease.

Dosage

The dosage of Lamivudine with Stavudine may vary based on individual patient factors and the specific ART regimen prescribed by a healthcare professional. It is typically taken orally, with or without food. Patients should follow their healthcare provider's instructions and adhere to the prescribed dosage schedule.

Contra-Indications

Lamivudine with Stavudine is contraindicated in individuals with known hypersensitivity to any of its components. It is essential for healthcare providers to be aware of the patient's medical history and potential drug allergies.

Special Precautions

-Patients with a history of peripheral neuropathy or pancreatitis may require special monitoring. -Regular monitoring of renal function is recommended. -Caution is advised in patients with liver dysfunction.

Side Effects

Common side effects may include nausea, vomiting, headache, fatigue, and peripheral neuropathy. Patients should promptly report any severe or persistent side effects to their healthcare provider.

Drug Interactions

Lamivudine with Stavudine may interact with other medications, potentially affecting their efficacy or leading to adverse effects. Inform the healthcare provider about all prescribed and over-the-counter drugs, as well as herbal supplements.